loading page

The effect of aortic esophageal fistula treatment after TEVAR with artificial vessel bypass(Single center clinical experience)
  • +3
  • Tiansheng Tang,
  • Taoyuan Wang,
  • Zhiwei Ding,
  • Changjuan Wu,
  • Kaitao Jian,
  • Jianshi Liu
Tiansheng Tang
Tianjin Medical University

Corresponding Author:[email protected]

Author Profile
Taoyuan Wang
Author Profile
Zhiwei Ding
Author Profile
Changjuan Wu
Author Profile
Kaitao Jian
Author Profile
Jianshi Liu
Author Profile

Abstract

Objective: To investigate the effect of aortic esophageal fistula treatment after thoracic aortic endovascular repair (TEVAR) with artificial vessel bypass. Methods: The clinical data of 6 consecutive patients who received surgical treatment at Shanghai Deda Hospital from September 2019 to June 2021 due to aortic esophageal fistula after TEVAR were retrospectively analyzed. There were 6 males, aged (47.7±8.2) years old (range: 35-56 years old). All patients had recurrent fever, and 4 patients had positive blood cultures. According to the specific conditions of the patients, all patients underwent artificial blood vessel bypass and jejunostomy under general anesthesia without extracorporeal circulation. One case underwent artificially infected vascular segment resection and esophageal repair at the same time. 5 cases underwent artificial infection vascular resection, 4 of them underwent esophageal repair, and 1 case had a large intraoperative fistula and local resection of the esophagus. Sensitive antibacterial drugs were continued after the operation for 6 to 8 weeks. Results: There were 2 deaths in hospital, 1 case of large cerebral infarction early postoperatively, and 1 case of septic shock. The remaining 4 patients recovered well after the operation and were discharged. The follow-up period was 2 to 23 months. During the follow-up period, the remaining patients had no recurrence of infection and esophageal fistula. Conclusion :In patients with aortic esophageal fistula after TEVAR, the establishment of artificial vascular bypass, the resection of the infected vascular segment, contemporaneous or staged esophageal repair, regular anti-infective treatment can obtain a good prognosis.
20 Aug 2021Submitted to Journal of Cardiac Surgery
21 Aug 2021Submission Checks Completed
21 Aug 2021Assigned to Editor
22 Aug 2021Reviewer(s) Assigned
05 Sep 2021Review(s) Completed, Editorial Evaluation Pending
05 Sep 2021Editorial Decision: Revise Minor